These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23272069)

  • 1. Diagnostic peptide discovery: prioritization of pathogen diagnostic markers using multiple features.
    Carmona SJ; Sartor PA; Leguizamón MS; Campetella OE; Agüero F
    PLoS One; 2012; 7(12):e50748. PubMed ID: 23272069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APRANK: Computational Prioritization of Antigenic Proteins and Peptides From Complete Pathogen Proteomes.
    Ricci AD; Brunner M; Ramoa D; Carmona SJ; Nielsen M; Agüero F
    Front Immunol; 2021; 12():702552. PubMed ID: 34335615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards High-throughput Immunomics for Infectious Diseases: Use of Next-generation Peptide Microarrays for Rapid Discovery and Mapping of Antigenic Determinants.
    Carmona SJ; Nielsen M; Schafer-Nielsen C; Mucci J; Altcheh J; Balouz V; Tekiel V; Frasch AC; Campetella O; Buscaglia CA; Agüero F
    Mol Cell Proteomics; 2015 Jul; 14(7):1871-84. PubMed ID: 25922409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenomic screening approach to identify new antigens for the serological diagnosis of chronic Chagas' disease.
    Elisei RMT; Matos CS; Carvalho AMRS; Chaves AT; Medeiros FAC; Barbosa R; Marcelino AP; Dos Santos Emidio K; Coelho EAF; Duarte MC; de Oliveira Mendes TA; da Costa Rocha MO; Menezes-Souza D
    Appl Microbiol Biotechnol; 2018 Jul; 102(14):6069-6080. PubMed ID: 29736822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification and characterization of epitopes in the 30-34 kDa Trypanosoma cruzi proteins recognized by antibodies in the serum samples of chagasic patients.
    Verissimo da Costa GC; Lery LM; da Silva ML; Moura H; Peralta RH; von Krüger WM; Bisch PM; Barr JR; Peralta JM
    J Proteomics; 2013 Mar; 80():34-42. PubMed ID: 23159400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes.
    Mucci J; Carmona SJ; Volcovich R; Altcheh J; Bracamonte E; Marco JD; Nielsen M; Buscaglia CA; Agüero F
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005972. PubMed ID: 28991925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retro-inverso peptide analogues of Trypanosoma cruzi B13 protein epitopes fail to be recognized by human sera and peripheral blood mononuclear cells.
    Iwai LK; Duranti MA; Abel LC; Juliano MA; Kalil J; Juliano L; Cunha-Neto E
    Peptides; 2001 Jun; 22(6):853-60. PubMed ID: 11390013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antigens for the serological diagnosis of human visceral leishmaniasis identified by immunogenomic screening.
    Carvalho AMRS; Mendes TAO; Coelho EAF; Duarte MC; Menezes-Souza D
    PLoS One; 2018; 13(12):e0209599. PubMed ID: 30571783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Reactivity Using Chimeric Trypanosoma cruzi Antigens: Diagnostic Performance in Settings Where Chagas Disease and American Cutaneous or Visceral Leishmaniasis Are Coendemic.
    Daltro RT; Leony LM; Freitas NEM; Silva ÂAO; Santos EF; Del-Rei RP; Brito MEF; Brandão-Filho SP; Gomes YM; Silva MS; Donato ST; Jeronimo SMB; Monteiro GRG; Carvalho LP; Magalhães AS; Zanchin NIT; Celedon PAF; Santos FLN
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refining wet lab experiments with in silico searches: A rational quest for diagnostic peptides in visceral leishmaniasis.
    Bremer Hinckel BC; Marlais T; Airs S; Bhattacharyya T; Imamura H; Dujardin JC; El-Safi S; Singh OP; Sundar S; Falconar AK; Andersson B; Litvinov S; Miles MA; Mertens P
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007353. PubMed ID: 31059497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From genome screening to creation of vaccine against Trypanosoma cruzi by use of immunoinformatics.
    Teh-Poot C; Tzec-Arjona E; Martínez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Dumonteil E
    J Infect Dis; 2015 Jan; 211(2):258-66. PubMed ID: 25070943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TEPITOPEpan: extending TEPITOPE for peptide binding prediction covering over 700 HLA-DR molecules.
    Zhang L; Chen Y; Wong HS; Zhou S; Mamitsuka H; Zhu S
    PLoS One; 2012; 7(2):e30483. PubMed ID: 22383964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome based screening of epitope ensemble vaccine candidates against dreadful visceral leishmaniasis using immunoinformatics approach.
    Singh G; Pritam M; Banerjee M; Singh AK; Singh SP
    Microb Pathog; 2019 Nov; 136():103704. PubMed ID: 31479726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.
    Eickhoff CS; Van Aartsen D; Terry FE; Meymandi SK; Traina MM; Hernandez S; Martin WD; Moise L; De Groot AS; Hoft DF
    Hum Vaccin Immunother; 2015; 11(9):2322-8. PubMed ID: 26107442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating in silico and in vitro analysis of peptide binding affinity to HLA-Cw*0102: a bioinformatic approach to the prediction of new epitopes.
    Walshe VA; Hattotuwagama CK; Doytchinova IA; Wong M; Macdonald IK; Mulder A; Claas FH; Pellegrino P; Turner J; Williams I; Turnbull EL; Borrow P; Flower DR
    PLoS One; 2009 Nov; 4(11):e8095. PubMed ID: 19956609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the antigenic properties of the L. infantum Hsp70: design of synthetic peptides for specific serodiagnosis of human leishmaniasis.
    Quijada L; Requena JM; Soto M; Alonso C
    Immunol Lett; 1998 Oct; 63(3):169-74. PubMed ID: 9840686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment on epitope prediction methods for protozoa genomes.
    Resende DM; Rezende AM; Oliveira NJ; Batista IC; Corrêa-Oliveira R; Reis AB; Ruiz JC
    BMC Bioinformatics; 2012 Nov; 13():309. PubMed ID: 23170965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.
    Kashyap M; Jaiswal V; Farooq U
    Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The farther the better: Investigating how distance from human self affects the propensity of a peptide to be presented on cell surface by MHC class I molecules, the case of Trypanosoma cruzi.
    Vergni D; Gaudio R; Santoni D
    PLoS One; 2020; 15(12):e0243285. PubMed ID: 33284846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proteomic road to acquire an accurate serological diagnosis for human tegumentary leishmaniasis.
    Lima BS; Pires SF; Fialho LC; Oliveira EJ; Machado-de-Avila RA; Chávez-Olórtegui C; Chapeaurouge AD; Perales J; Andrade HM
    J Proteomics; 2017 Jan; 151():174-181. PubMed ID: 27262223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.